ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc.

Overview
Date Founded

2001

Headquarters

210 Main Street West, Baudette, MN, 56623, USA

Type of Company

Public

Employees (Worldwide)

369

Industries

Pharmaceuticals
Industrial Machinery & Manufacturing
Hospitals & Patient Services
Biotechnology

Company Description

BioSante´s corporate strategy is to develop high value medically-needed pharmaceutical products and to implement strategic alternatives with respect to its products and its company, including licenses, business collaborations and other business combinations or transactions with other pharmaceutical and biotechnology companies. BioSante´s products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD), which is in Phase III development. BioSante also is developing a portfolio of cancer vaccines, with 17 Phase I and Phase II clinical trials currently on-going. Four of these vaccines have been granted Orphan Drug designation by the U.S. Food and Drug Administration (FDA). BioSante´s other products include an FDA-approved testosterone gel for male hypogonadism, which is licensed to Teva Pharmaceuticals USA, Inc., and the Pill-Plus™, an oral contraceptive in Phase II clinical development by Pantarhei Bioscience B.V. BioSante´s first FDA-approved product, Elestrin™ (estradiol gel) indicated for the treatment of hot flashes associated with menopause, is marketed in the U.S. by Meda Pharmaceuticals, BioSante´s licensee.

Contact Data
Trying to get in touch with decision makers at ANI Pharmaceuticals, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Chief Financial Officer, Treasurer & Secretary

Chief Financial Officer, Secretary & Vice President

General Manager, Canadian Operations

Chief Commercial Officer & Head of Rare Diseases

Senior Vice President of Generics

Senior Vice President-Operations & Product Development

Head-Sales

Director

Vice President

Board of Directors

Chairman & Chief Executive Officer at Alcami Corp.

Co-Founder at Meridian Venture Partners LLC

Former President at Par Pharmaceutical Companies, Inc.

Founding Dean-College of Population Health at Thomas Jefferson University

General Counsel at Par Pharmaceutical Companies, Inc.

President & Chief Executive Officer at ANI Pharmaceuticals, Inc.

Executive Vice President at Tygrus LLC

Paths to ANI Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
ANI Pharmaceuticals, Inc.
Owners & Shareholders
Details Hidden

FWSM is a small- and mid-cap value manager that believes the investment process is best broken down into three components: research, trading and portfolio management. The characteristics they look for in the measurement of value include strong company management and history, relatively small debt and relatively a large cash position, expanding cash flow, earnings growth superior to its industry and the economy in general, p/e ratio below unweighted market average and ROE above industry average. The firm primarily uses fundamental analysis to determine which companies to purchase and sell. FWSM also utilize a variety of informational sources and strategies to make investment decisions.

Details Hidden

MS is an active growth-oriented investor and manages portfolios invested in global equity with a long-term outlook. The firm focuses on mid- and small-cap companies from the healthcare sector, including pharma, emerging pharma, biotech, genomics, medtech, drug delivery and e-health.MS uses computer models to continuously screen a selection of 700-800 listed companies as well as pre-IPOs for which they systematically collect data in a proprietary database. This information is completed by both in-house and third-party fundamental research

Details Hidden

FWSM is a small- and mid-cap value manager that believes the investment process is best broken down into three components: research, trading and portfolio management. The characteristics they look for in the measurement of value include strong company management and history, relatively small debt and relatively a large cash position, expanding cash flow, earnings growth superior to its industry and the economy in general, p/e ratio below unweighted market average and ROE above industry average. The firm primarily uses fundamental analysis to determine which companies to purchase and sell. FWSM also utilize a variety of informational sources and strategies to make investment decisions.

Recent Transactions
Details Hidden

ANI Pharmaceuticals, Inc. purchases Coeptis Pharmaceuticals, Inc. /7 Generic Drug Assets from Coeptis Pharmaceuticals, Inc.

Details Hidden

ANI Pharmaceuticals, Inc. purchases Amneal Pharmaceuticals LLC /Generic Products from Ae Cos. LLC

Details Hidden

ANI Pharmaceuticals, Inc. purchases Cranford Pharmaceuticals LLC /Inderal XL Assets from Juggernaut Capital Partners, Cranford Pharmaceuticals LLC

Transaction Advisors
Legal Advisor

Advised onANI Pharmaceuticals, Inc. purchases Cranford Pharmaceuticals LLC /Inderal XL Assets from Juggernaut Capital Partners, Cranford Pharmaceuticals LLC

Investment Advisor

Advised onANI Pharmaceuticals, Inc. purchases Cell Genesys, Inc.

Underwriter

Advised onANI Pharmaceuticals, Inc. issued USD Common Stock

Legal Advisor

Advised onANI Pharmaceuticals, Inc. purchases ANI Pharmaceuticals, Inc. (Inactive) from Meridian Venture Partners LLC

Legal Advisor

Advised onANI Pharmaceuticals, Inc. purchases ANI Pharmaceuticals, Inc. (Inactive) from Meridian Venture Partners LLC

Advisors & Consultants
Consultant

Former Chief Financial Officer & Vice President at ANI Pharmaceuticals, Inc.

Advisor

Founder at In-Site Communications, Inc.

Clients

Walgreens Boots Alliance, Inc. engages in the provision of drug store services. It operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreens business, which includes the operation of retail drugstores, health and wellness services, and mail and central specialty pharmacy services. The Retail Pharmacy International segment consists of pharmacy-led health and beauty retail businesses and optical practices. The Pharmaceutical Wholesale segment consists of the Alliance Healthcare pharmaceutical wholesaling and distribution businesses and an equity method investment in AmerisourceBergen. The company was founded in 1901 and is headquartered in Deerfield, IL.

CVS Health Corp. engages in the provision of health care services. It operates through the following segments: Pharmacy Services, Retail or Long Term Care, Health Care Benefits, and Corporate/Other. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise. The Health Care Benefits segment offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, medical management capabilities. The Corporate/Other segment involves in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Cigna Corp. is a global health service company, which is dedicated to improving the health, well-being and peace of mind. Its products and services include an integrated suite of health services such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits and other related products including group life, accident and disability insurance.

Key Stats and Financials As of 2020
Market Capitalization
$438M
Total Enterprise Value
$526M
Earnings Per Share
$-1.88
Revenue
$208M
Net Profit
$-22.6M
Total Equity
$196M
EBITDAMargin
13.94%
EBITDA
$29.1M
Enterprise Value / Sales
2.52x
Enterprise Value EBITDAOperating
18.07x
TEVNet Income
-23.31x
Debt TEV
0.35x
Total Debt
$186M
Three Year Compounded Annual Growth Rate Of Revenue
5.64%
Non-Profit Donations & Grants
Investments
Details Hidden

Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA.

Suppliers
Procaps SA Pharmaceuticals | Barranquilla, Colombia

Procaps SA manufactures gelatin capsules. The firm operates through four business units: Softigel, Farma, Clinical Specialties, Vital Care and Diabetrics. The company was founded by Ruben Minsky and is headquartered in Barranquilla, Colombia.

Competitors
Sun Pharmaceutical Industries Ltd. Pharmaceuticals - Mumbai, India

Sun Pharmaceutical We are an international speciality pharma company, with a large presence in the US and India, and a footprint across 41 other markets. In the US, which is our largest market, we have built a strong pipeline of generics, directly and through our subsidiaries Caraco and Sun Pharmaceutical Inc. Taro adds strong dermatology range to this portfolio. In India and rest of the world markets, our brands are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, diabetology, ophthalmology, orthopedics etc. We are market leaders in speciality therapy areas in India. We retain the drive for growth that marked our early days, when we had. begun in 1983 with just 5 products. Since then, we have crossed several milestones to emerge as a leading pharma company in India where we are the 5th largest by prescription sales, a rank that we have retained over a decade. (IMS ORG Stockist Audit, March. 2012) Since the mid- nineties, we have used a combination of growth and acquisition to drive growth. important acquisitions have included those of the US, detroit-based Caraco Parma Labs and a plant at Halol which now holds UKMHRA and USFDA approvals. The 2010 acquisition of Taro Pharmaceuticals doubles our US business and brings us strengths in dermatology and pediatrics

Viatris, Inc. Pharmaceuticals - Canonsburg, PA

Viatris, Inc. is a global healthcare company, which engages in the provision of access to medicines, sustainable operations. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan and Hong Kong. The JANZ segment consists of operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses operations with developing markets and emerging economies including countries in Asia, the Middle East, South and Central America, Africa and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

Glenmark Pharmaceuticals Ltd. Pharmaceuticals - Mumbai, India

Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture and marketing of pharmaceutical products. It operates through the following geographical segments: India, North America, Latin America, Europe, and Rest of the World. The company was founded by Gracias Saldanha on November 18, 1977 and is headquartered in Mumbai, India.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by ANI Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of ANI Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and ANI Pharmaceuticals, Inc..